BeOne Medicines (BEIGF) EBT (QoQ) (2015 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) EBT (QoQ) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.54% |
| Mar 31, 2026 | 73.69% |
| Dec 31, 2025 | 1.41% |
| Sep 30, 2025 | 47.83% |
| Jun 30, 2025 | 376.31% |
| Mar 31, 2025 | 124.49% |
| Dec 31, 2024 | 13.18% |
| Sep 30, 2024 | 7.19% |
| Jun 30, 2024 | 56.49% |
| Mar 31, 2024 | 30.60% |
| Dec 31, 2023 | -252.95% |
| Sep 30, 2023 | 162.41% |
| Jun 30, 2023 | -9.06% |
| Mar 31, 2023 | 21.82% |
| Dec 31, 2022 | 21.82% |
| Sep 30, 2022 | 1.14% |
| Jun 30, 2022 | -32.36% |
| Mar 31, 2022 | 28.21% |
| Dec 31, 2021 | -35.50% |
| Sep 30, 2021 | 9.88% |